Diagnostic performance of an automated plasma p-tau217 chemiluminescent assay for detecting Aβ pathology in a Chinese memory clinic cohort
Open Access
- 5 June 2026
- journal article
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (7) , 100613
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Department, Henan Province (241111313500)
- International Science and Technology Cooperation Programme (252102521060)
- National Natural Science Foundation of China (82201471)
This publication has 28 references indexed in Scilit:
- Evidence‐based standardized sample handling protocol for accurate blood‐based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization ConsortiumAlzheimer's & Dementia, 2025
- Alzheimer's Association Clinical Practice Guideline on the use of blood‐based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settingsAlzheimer's & Dementia, 2025
- Diagnostic accuracy of plasma p‐tau217/Aβ42 for Alzheimer's disease in clinical and community cohortsAlzheimer's & Dementia, 2025
- Cut‐points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practiceAlzheimer's & Dementia, 2025
- A head‐to‐head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinicAlzheimer's & Dementia, 2025
- Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimerʼs disease in a Chinese cohortThe Journal Of Prevention of Alzheimer's Disease, 2025
- Plasma p‐tau217 and p‐tau217/Aβ1‐42 are effective biomarkers for identifying CSF‐ and PET imaging‐diagnosed Alzheimer's disease: Insights for research and clinical practiceAlzheimer's & Dementia, 2025
- Plasma p‐tau 217 and neurofilament/p‐tau 217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degenerationAlzheimer's & Dementia, 2025
- Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyJAMA Neurology, 2024
- International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer’s DiseasePhenomics, 2022